Diatos and Servier Announce Oncology Research Collaboration

Diatos S.A., a Paris-based privately held biopharmaceutical company, and Servier, France's largest privately owned pharmaceutical company, announced a research collaboration involving FTE support and a license option to apply the Diatos Vectocell technology to Servier's oncology research program in order to enhance the efficacy and safety of a Servier small molecule drug candidate.